Recruiting
Atrial fibrillation+1
RecruitingStudy of drug combination therapy for prevention of recurrent stroke in patients with acute ischemic stroke and atrial fibrillation
Registered drugNo placebo
Study of drug combination therapy for prevention of recurrent stroke in patients with acute ischemic stroke and atrial fibrillation
Registered drugNo placebo
- Disease:Atrial fibrillationIschaemic stroke
- Substances:Flecainide AcetateAmiodarone Hydrochloride+2
Countries:
Germany
Germany- Participants:18–64 years · 65+ years
- Substances:Flecainide Acetate


